InvestorsHub Logo
icon url

John_Langston

04/05/15 5:28 PM

#150045 RE: kayak_wench #150033

If Elite has a cheaper product



LMAO; Elite doesn't have a product!!!!!!
icon url

WeeZuhl

04/05/15 10:55 PM

#150078 RE: kayak_wench #150033

You are 100% correct, kayak wrench


In my personal experience it isn't the doctor that drives changes in my prescriptions, but my insurance company.




I don’t think physicians are going to change a patient who is on a stable, effective chronic pain regimen to an entirely different medication just because naltrexone-based ADT becomes available. I don’t even like to change BP meds from one ACE-inhibitor to another or one calcium channel blocker to another. It creates problems, phone calls, confusion, phantom side effects, unhappy patients. The transition away from one medication to another will only happen when the patient-physician conversation can start with the one of the following phrases:

A. State/federal law mandates that I do this…
B. Your insurance company will only pay for this new medication…
C. The FDA has taken your medication off the market…


http://www.theonion.com/articles/physician-shoots-off-a-few-adderall-prescriptions,35718/
icon url

Jimmy Joe

04/06/15 1:23 PM

#150110 RE: kayak_wench #150033

kayak wench... not only if Elite has a cheaper product... think of the liability issues here.

If an opioid is available with ADT/ART versus an opioid without.
No doubt in my mind a healthcare professional will choose the opioid with the ADT/ART. Insurance companies will keep this in mind too.